Paper39201745
Nucleoside Reverse Transcriptase Inhibitors Are the Major Class of HIV Antiretroviral Therapeutics That Induce Neuropathic Pain in Mice.
Bush K and 2 others. Int J Mol Sci, 2024. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Nucleoside Reverse Transcriptase Inhibitors Are the Major Class of HIV Antiretroviral Therapeutics That Induce Neuropathic Pain in Mice. Papers, record 39201745. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39201745
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Nucleoside Reverse Transcriptase Inhibitors Are the Major Class of HIV Antiretroviral Therapeutics That Induce Neuropathic Pain in Mice.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neuralgia | Major topic |
| Reverse Transcriptase Inhibitors | Major topic |
| Animals | |
| Mice | |
| Male | |
| HIV Infections | |
| Anti-HIV Agents | |
| Disease Models, Animal | |
| Peripheral Nervous System Diseases | |
| Mice, Inbred C57BL |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 NS079166 | NINDS NIH HHS | United States | R01NS079166 | PubMed | NIH RePORTER |
| R01DA057195, R01NS095747, R01NS079166, R01DA050530 | NIH HHS | United States | R01DA057195 | PubMed | NIH RePORTER |
| R01 NS095747 | NINDS NIH HHS | United States | R01NS095747 | PubMed | NIH RePORTER |
| R01 DA036165 | NIDA NIH HHS | United States | R01DA036165 | PubMed | NIH RePORTER |
| R01 DA062257 | NIDA NIH HHS | United States | R01DA062257 | PubMed | NIH RePORTER |
| R01 DA057195 | NIDA NIH HHS | United States | R01DA057195 | PubMed | NIH RePORTER |
| R01 DA050530 | NIDA NIH HHS | United States | R01DA050530 | PubMed | NIH RePORTER |
References92
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30758073 | Dissection of Merkel cell formation in hairy and glabrous skin reveals a common requirement for FGFR2-mediated signalling. | Exp Dermatol | 2019 | https://conductscience.org/library/papers/30758073 | PubMed |
| 2 | 30885900 | Ibalizumab, a Novel Monoclonal Antibody for the Management of Multidrug-Resistant HIV-1 Infection. | Antimicrob Agents Chemother | 2019 | https://conductscience.org/library/papers/30885900 | PubMed |
| 3 | 16251317 | Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity. | Antimicrob Agents Chemother | 2005 | https://conductscience.org/library/papers/16251317 | PubMed |
| 4 | 8382349 | 2',3'-dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients. | Neurology | 1993 | https://conductscience.org/library/papers/8382349 | PubMed |
| 5 | 28487145 | Unmasking efavirenz neurotoxicity: Time matters to the underlying mechanisms. | Eur J Pharm Sci | 2017 | https://conductscience.org/library/papers/28487145 | PubMed |
| 6 | 30069830 | Nanoformulated Antiretroviral Therapy Attenuates Brain Metabolic Oxidative Stress. | Mol Neurobiol | 2019 | https://conductscience.org/library/papers/30069830 | PubMed |
| 7 | 24633867 | Gp120 in the pathogenesis of human immunodeficiency virus-associated pain. | Ann Neurol | 2014 | https://conductscience.org/library/papers/24633867 | PubMed |
| 8 | 27984559 | Psychiatric Symptoms in Patients Receiving Dolutegravir. | J Acquir Immune Defic Syndr | 2017 | https://conductscience.org/library/papers/27984559 | PubMed |
| 9 | 11950737 | Drug points: Neuropsychiatric complications of nevirapine treatment. | BMJ | 2002 | https://conductscience.org/library/papers/11950737 | PubMed |
| 10 | 18724802 | A report on the effect of commencing enfuvirtide on peripheral neuropathy. | AIDS Res Hum Retroviruses | 2008 | https://conductscience.org/library/papers/18724802 | PubMed |
| 11 | 30659539 | Structure Based Drug Design: Clinically Relevant HIV-1 Integrase Inhibitors. | Curr Top Med Chem | 2018 | https://conductscience.org/library/papers/30659539 | PubMed |
| 12 | 25011651 | Lack of mitochondrial toxicity of darunavir, raltegravir and rilpivirine in neurons and hepatocytes: a comparison with efavirenz. | J Antimicrob Chemother | 2014 | https://conductscience.org/library/papers/25011651 | PubMed |
| 13 | 28646196 | Nucleoside reverse transcriptase inhibitors (NRTIs) induce proinflammatory cytokines in the CNS via Wnt5a signaling. | Sci Rep | 2017 | https://conductscience.org/library/papers/28646196 | PubMed |
| 14 | 21198432 | Long-term safety from the raltegravir clinical development program. | Curr HIV Res | 2011 | https://conductscience.org/library/papers/21198432 | PubMed |
| 15 | 21174240 | HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. | J Neurovirol | 2011 | https://conductscience.org/library/papers/21174240 | PubMed |
| 16 | 23963694 | A review of the toxicity of HIV medications. | J Med Toxicol | 2014 | https://conductscience.org/library/papers/23963694 | PubMed |
| 17 | 30043070 | Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel. | JAMA | 2018 | https://conductscience.org/library/papers/30043070 | PubMed |
| 18 | 10747817 | NNRTIs-a new class of drugs for HIV. | J Antimicrob Chemother | 2000 | https://conductscience.org/library/papers/10747817 | PubMed |
| 19 | 31341225 | Administration of Tramadol or Buprenorphine via the drinking water for post-operative analgesia in a mouse-osteotomy model. | Sci Rep | 2019 | https://conductscience.org/library/papers/31341225 | PubMed |
| 20 | 10882161 | HIV-associated peripheral neuropathy: epidemiology, pathophysiology and treatment. | Drugs | 2000 | https://conductscience.org/library/papers/10882161 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41027876 | Inhibition of long interspersed nuclear element-1 by nucleoside reverse transcriptase inhibitors attenuates vascular calcification. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/41027876 | PubMed |
| 39771570 | Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Induced Neuropathy and Mitochondrial Toxicity: Limitations of the Poly-γ Hypothesis and the Potential Roles of Autophagy and Drug Transport. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39771570 | PubMed |
| 37857809 | Pathogenic mechanisms of human immunodeficiency virus (HIV)-associated pain. | Mol Psychiatry | 2023 | https://conductscience.org/library/papers/37857809 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39201745
GET https://conductscience.org/api/papers/v1/39201745/references?page=2